1-2 of 2
drug pricing
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Incremental Financial and Health-Related Burden of Novel Drugs Used in the Treatment of Relapsed and/or Refractory Multiple Myeloma (RRMM): A Meta-Analysis of Phase III Randomized Controlled Trials (RCTs)

Binod Dhakal, MBBS, Ravi Narra, MD, Timothy Smunt, MBA, Angela Canadeo, Pharm D, Saurabh Chhabra, MD, Anita d'Souza, MBBS, MD, Bishal Gyawali, MD PhD, Parameswaran Hari, MD MRCP, MS, Saroj Niraula, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3403.
https://doi.org/10.1182/blood.V130.Suppl_1.3403.3403
Published: 2017
Journal Articles

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

Experts in Chronic Myeloid Leukemia
Journal: Blood
Blood (2013) 121 (22): 4439–4442.
https://doi.org/10.1182/blood-2013-03-490003
Published: 2013
Includes: Supplemental data